Your browser is no longer supported. Please, upgrade your browser.
Settings
EDGE Edge Therapeutics, Inc. daily Stock Chart
EDGE [NASD]
Edge Therapeutics, Inc.
Index- P/E- EPS (ttm)-1.56 Insider Own0.30% Shs Outstand31.04M Perf Week11.31%
Market Cap384.90M Forward P/E- EPS next Y-1.85 Insider Trans-34.64% Shs Float23.28M Perf Month31.91%
Income-46.50M PEG- EPS next Q-0.44 Inst Own50.80% Short Float3.25% Perf Quarter21.57%
Sales- P/S- EPS this Y66.50% Inst Trans0.08% Short Ratio9.29 Perf Half Y18.89%
Book/sh2.42 P/B5.12 EPS next Y-10.80% ROA-43.70% Target Price19.00 Perf Year14.08%
Cash/sh3.13 P/C3.96 EPS next 5Y- ROE-56.90% 52W Range7.30 - 12.20 Perf YTD32.34%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High1.64% Beta-
Dividend %- Quick Ratio8.30 Sales past 5Y- Gross Margin- 52W Low69.84% ATR0.63
Employees31 Current Ratio8.30 Sales Q/Q- Oper. Margin- RSI (14)76.92 Volatility7.86% 5.83%
OptionableNo Debt/Eq0.27 EPS Q/Q1.80% Profit Margin- Rel Volume1.72 Prev Close11.55
ShortableYes LT Debt/Eq0.20 EarningsJan 31 BMO Payout- Avg Volume81.50K Price12.40
Recom1.70 SMA2022.31% SMA5025.94% SMA20022.50% Volume140,432 Change7.36%
Jan-18-18Resumed Credit Suisse Outperform $17
Mar-03-17Resumed Leerink Partners Outperform $21
Oct-26-15Initiated Leerink Partners Outperform
Oct-26-15Initiated JMP Securities Mkt Outperform
Oct-26-15Initiated Credit Suisse Outperform
Dec-29-17 04:05PM  Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis GlobeNewswire
Nov-28-17 04:26PM  Edited Transcript of EDGE earnings conference call or presentation 1-Nov-17 12:30pm GMT Thomson Reuters StreetEvents
Nov-06-17 07:00AM  Edge Therapeutics to Present at the 26th Annual Credit Suisse Healthcare Conference GlobeNewswire
Nov-01-17 07:55AM  Is Edge Therapeutics Incs (EDGE) Balance Sheet A Threat To Its Future? Simply Wall St.
07:05AM  Edge Therapeutics reports 3Q loss Associated Press
07:00AM  Edge Therapeutics Reports Third Quarter 2017 Financial Results GlobeNewswire
Oct-18-17 07:00AM  Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017 GlobeNewswire
Oct-06-17 07:00AM  Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting GlobeNewswire
Sep-20-17 07:00AM  Edge Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
Sep-19-17 07:00AM  Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors GlobeNewswire
Aug-16-17 06:15PM  Edited Transcript of EDGE earnings conference call or presentation 1-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-01-17 10:59PM  Edge Therapeutics reports 2Q loss Associated Press
06:45AM  Investor Network: Edge Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
06:30AM  Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress GlobeNewswire
Jul-29-17 06:45AM  3 Biotech Stocks for Enterprising Investors Motley Fool
Jul-18-17 07:00AM  Edge Therapeutics Announces Second Quarter Financial Results Conference Call on August 1, 2017 GlobeNewswire
Jul-06-17 06:30AM  Edge Therapeutics Announces Commercial Supply Agreement for EG-1962 with Oakwood Laboratories GlobeNewswire
Jun-15-17 07:00AM  Edge Therapeutics to Participate in the JMP Securities Life Science Conference GlobeNewswire
Jun-08-17 06:30AM  Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency GlobeNewswire
Jun-02-17 07:00AM  Edge Therapeutics to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-10-17 07:00AM  Edge Therapeutics to Present at Bank of America Merrill Lynch 2017 Health Care Conference GlobeNewswire
May-04-17 08:45AM  Edited Transcript of EDGE earnings conference call or presentation 3-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-03-17 07:05AM  Investor Network: Edge Therapeutics, Inc. to Host Earnings Call Accesswire
06:36AM  Edge Therapeutics reports 1Q loss Associated Press
06:30AM  Edge Therapeutics Reports First Quarter 2017 Financial Results and Continued Operational Progress GlobeNewswire
Apr-21-17 07:00AM  Edge Therapeutics Announces Conference Call on May 3, 2017 to Discuss First Quarter 2017 Financial Results GlobeNewswire
Apr-19-17 11:30AM  Edge Therapeutics Rises Following Registered Direct Offering Announcement 24/7 Wall St.
06:30AM  Edge Therapeutics Announces $18 Million Registered Direct Offering of Common Stock GlobeNewswire
Mar-29-17 07:00AM  Edge Therapeutics to Present at Needham & Companys 16th Annual Healthcare Conference GlobeNewswire +5.73%
Mar-15-17 04:17PM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statem
Mar-13-17 09:25AM  Edge Therapeutics Announces First Patient Randomized in Study of Intracisternal Administration of EG-1962 in Adults with Aneurysmal Subarachnoid Hemorrhage GlobeNewswire
09:17AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-08-17 01:04PM  EDGE THERAPEUTICS, INC. Financials
Mar-03-17 07:00AM  Edge Therapeutics to Present at Cowen and Company 37th Annual Healthcare Conference on March 8, 2017 GlobeNewswire -5.53%
03:25AM  Edited Transcript of EDGE earnings conference call or presentation 2-Mar-17 1:30pm GMT Thomson Reuters StreetEvents
Mar-02-17 08:30AM  Edge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:07AM  Q4 2016 Edge Therapeutics Inc Earnings Release - Time Not Supplied
07:01AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
06:39AM  Edge Therapeutics reports 4Q loss Associated Press
06:30AM  Edge Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-23-17 07:00AM  Edge Therapeutics Announces Conference Call on March 2, 2017 to Discuss Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-21-17 07:00AM  Edge Therapeutics Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs and Makes Inducement Grant under NASDAQ Rule 5635(c)(4) GlobeNewswire
Feb-17-17 07:00AM  Edge Therapeutics EG-1962 Data To Be Presented at International Stroke Conference 2017 GlobeNewswire
Feb-08-17 07:00AM  Edge Therapeutics to Present at Investor Conferences in February GlobeNewswire
Dec-15-16 10:36AM  Edge Therapeutics, Inc. :EDGE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 15, 2016
Dec-09-16 09:18AM  Edge Therapeutics Announces Publication of Phase 1/2 Data on EG-1962 for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Peer-Reviewed Medical Journal, Stroke GlobeNewswire
Nov-02-16 11:10AM  Edited Transcript of EDGE earnings conference call or presentation 1-Nov-16 12:30pm GMT
07:30AM  Edge Therapeutics to Present at Investor Conferences in November GlobeNewswire
Nov-01-16 08:30AM  Edge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:31AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
07:07AM  Q3 2016 Edge Therapeutics Inc Earnings Release - Time Not Supplied
06:37AM  Edge Therapeutics reports 3Q loss
06:30AM  Edge Therapeutics Reports Third Quarter Financial Results GlobeNewswire
Oct-25-16 07:00AM  Edge Therapeutics to Host Conference Call on November 1, 2016 to Discuss Third Quarter Financial Results GlobeNewswire
Oct-18-16 06:06AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statem
Oct-17-16 08:30AM  Edge Therapeutics Appoints Chief Operating Officer and Makes Inducement Grant under NASDAQ Rule 5635(c)(4) GlobeNewswire
Oct-11-16 02:34PM  Edge Therapeutics, Inc. :EDGE-US: Earnings Analysis: Q2, 2016 By the Numbers : October 11, 2016
Sep-08-16 07:30AM  Edge Therapeutics to Present at the Leerink Partners Rare Disease & Immuno-Oncology Roundtable Series and Participate in Additional Investor Conferences in September GlobeNewswire +5.73%
Sep-06-16 04:01PM  Edge Therapeutics Announces Additional Pharmacokinetic Data Supporting the Potential Clinical and Health Economic Impact of EG-1962 in Aneurysmal Subarachnoid Hemorrhage GlobeNewswire
Sep-01-16 04:01PM  Edge Therapeutics to Present Additional Data from Phase 1/2 NEWTON Study of EG-1962 at Two Scientific Conferences in September GlobeNewswire
Aug-19-16 10:00AM  Edge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Aug-04-16 07:11AM  Edited Transcript of EDGE earnings conference call or presentation 3-Aug-16 12:30pm GMT
Aug-03-16 08:30AM  Edge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
07:31AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
07:07AM  Q2 2016 Edge Therapeutics Inc Earnings Release - Before Market Open
06:48AM  Edge Therapeutics reports 2Q loss
06:30AM  Edge Therapeutics Reports Second Quarter Financial Results and Recent Highlights GlobeNewswire
Aug-02-16 09:55AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia
06:30AM  Edge Therapeutics Announces Closing of $20 Million Debt Facility with Hercules Capital, Inc. GlobeNewswire
Aug-01-16 08:33AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jul-29-16 06:30AM  Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage GlobeNewswire
Jul-27-16 07:30AM  Edge Therapeutics to Host Conference Call on August 3, 2016 to Discuss Second Quarter Financial Results GlobeNewswire
Jul-06-16 04:30PM  Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development GlobeNewswire
Jun-24-16 04:17PM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -6.32%
Jun-10-16 09:17AM  Will Edge Therapeutics (EDGE) Continue to Surge Higher?
Jun-02-16 01:03PM  Edge Therapeutics, Inc. :EDGE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016
08:00AM  Edge Therapeutics (EDGE) Catches Eye: Stock Soars 19.4%
07:30AM  Edge Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire
May-16-16 03:46PM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
May-13-16 07:30AM  Edge Therapeutics Receives FDA Fast Track Designation for EG-1962 for the Treatment of Subarachnoid Hemorrhage GlobeNewswire
May-12-16 09:00AM  Investors' Radars Failed to Catch Edge Therapeutics (EDGE), Has Yours?
May-03-16 08:30AM  Edge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today
08:28AM  Edge Therapeutics reports 1Q loss
07:31AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
07:07AM  Q1 2016 Edge Therapeutics Inc Earnings Release - Time Not Supplied CCBN
07:00AM  Edge Therapeutics Reports First Quarter 2016 Financial Results GlobeNewswire
Apr-26-16 09:00AM  Edge Therapeutics to Host a Conference Call on May 3, 2016 to Discuss First Quarter 2016 Financial Results GlobeNewswire
Apr-14-16 08:15AM  Edge Therapeutics (EDGE) in Focus: Stock Rises 6.7%
Apr-05-16 09:00AM  Edge Therapeutics to Present at the 15th Annual Needham Healthcare Conference GlobeNewswire
Mar-30-16 08:58AM  Edge Therapeutics (EDGE) Rises: Stock Up 7.7% in Session +12.56%
Mar-26-16 12:01AM  [$$] Edge Therapeutics' Advantage at Barrons.com
Mar-16-16 01:22PM  5 Stocks Insiders Love Right Now at TheStreet
Mar-09-16 10:34AM  Edited Transcript of EDGE earnings conference call or presentation 8-Mar-16 1:30pm GMT -9.51%
Mar-08-16 08:30AM  Edge Therapeutics Inc Earnings Call scheduled for 8:30 am ET today -5.13%
07:23AM  Edge Therapeutics reports 4Q loss
07:16AM  EDGE THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
07:07AM  Q4 2015 Edge Therapeutics Inc Earnings Release - Time Not Supplied
07:00AM  Edge Therapeutics Reports Fourth Quarter and Full-Year 2015 Financial Results GlobeNewswire
Mar-02-16 08:00AM  Edge Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference GlobeNewswire +9.67%
Mar-01-16 08:00AM  Edge Therapeutics to Host a Conference Call on March 8, 2016 to Discuss Fourth Quarter and Full-Year 2015 Financial Results GlobeNewswire
Developing a sustained-release therapy for limiting brain injury after aneurysms.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leuthner Brian APresident and CEOJan 03Sale10.112,50025,27585,236Jan 03 06:48 PM
Leuthner Brian APresident and CEOJan 02Sale10.112,50025,27587,736Jan 03 06:48 PM
Leuthner Brian APresident and CEODec 05Sale9.682,50024,20090,236Dec 05 05:39 PM
Leuthner Brian APresident and CEODec 04Sale9.972,50024,92592,736Dec 05 05:39 PM
Leuthner Brian APresident and CEODec 01Sale9.922,50024,80095,236Dec 05 05:39 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerNov 22Sale10.003,36133,6100Nov 22 03:08 PM
Leuthner Brian APresident and CEONov 03Sale10.862,50027,15097,736Nov 03 05:53 PM
Leuthner Brian APresident and CEONov 02Sale10.942,50027,350100,236Nov 03 05:53 PM
Leuthner Brian APresident and CEONov 01Sale10.922,50027,300102,736Nov 03 05:53 PM
Leuthner Brian APresident and CEOOct 04Sale11.142,50027,850105,236Oct 04 05:52 PM
Leuthner Brian APresident and CEOOct 03Sale10.932,50027,325107,736Oct 04 05:52 PM
Leuthner Brian APresident and CEOOct 02Sale10.812,50027,025110,236Oct 04 05:52 PM
Leuthner Brian APresident and CEOSep 06Sale10.312,50025,775112,736Sep 06 08:01 PM
Leuthner Brian APresident and CEOSep 05Sale9.942,50024,850115,236Sep 06 08:01 PM
Leuthner Brian APresident and CEOSep 01Sale10.372,50025,925117,736Sep 06 08:01 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerAug 29Sale10.422,50026,0503,361Aug 29 05:30 PM
MARCHIO ALBERT N IIChief Accounting & Adm OfficerAug 23Sale10.391,00010,3905,861Aug 24 04:11 PM
Leuthner Brian APresident and CEOAug 03Sale10.402,50026,000120,236Aug 03 08:45 PM
Leuthner Brian APresident and CEOAug 02Sale10.532,50026,325122,736Aug 03 08:45 PM
Leuthner Brian APresident and CEOAug 01Sale10.652,50026,625125,236Aug 03 08:45 PM
Leuthner Brian APresident and CEOJul 06Sale10.082,50025,200127,736Jul 06 05:50 PM
Leuthner Brian APresident and CEOJul 05Sale10.212,50025,525130,236Jul 06 05:50 PM
Leuthner Brian APresident and CEOJul 03Sale10.272,50025,675132,736Jul 06 05:50 PM
Leuthner Brian APresident and CEOApr 26Sale11.101001,110135,236May 09 03:33 PM
LOUGHLIN JAMES JDirectorMar 06Buy9.243,00027,7206,000Mar 07 03:33 PM
Leuthner Brian APresident and CEOFeb 07Sale9.521,50014,280245,479Feb 08 03:53 PM
Leuthner Brian APresident and CEOFeb 06Sale9.521,50014,280246,979Feb 07 04:12 PM
Leuthner Brian APresident and CEOFeb 03Sale9.691,50014,535248,479Feb 07 04:12 PM
Leuthner Brian APresident and CEOFeb 02Sale9.611,50014,415249,979Feb 03 03:25 PM
Leuthner Brian APresident and CEOFeb 01Sale9.381,50014,070251,479Feb 03 03:25 PM
Macdonald R. LochChief Scientific OfficerJan 23Option Exercise2.0425,00051,000595,602Jan 25 09:35 AM